CSM, a Clinigen company, enhances the clinical supply chain for biotechnology and pharmaceutical clinical trials worldwide since 1997.
Driven by quality, we offer a unique blend of traditional and innovative services that solve complex clinical trial supply problems, such as limited drug supply, time constraints, and patient enrollment.
With two facilities in Post-Brexit EU and three in the US, CSM is committed to ensuring clinical trials are a success, regardless of size or scope, from Phase I to Phase IV projects.
CSM innovates to make clinical trials more (cost-) efficient and reliable with specialized service solutions like Investigator Initiated Study services, On-Demand packaging and labelling, Direct-to-Patient shipping, QP services, and Biological Sample Management.
We employ highly trained staff that understands the importance of providing quality supplies to clinical sites and their patients. Our team is dedicated to improving timelines, decreasing costs and improving study quality for you.